Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Newly formed Radcliffe Department of Medicine launches

Events Research

The Radcliffe Department of Medicine (RDM) is today (25 March 2013) hosting its Inaugural Symposium. RDM, which is part of the University of Oxford’s Medical Sciences Division, brings together about 500 staff from several research areas.

Radcliffe Department of Medicine logoThe symposium showcased the breadth of research conducted within RDM and gave researchers from across the department the opportunity to hear about their colleagues work and share ideas. In an effort to increase internal collaborations, RDM has developed an innovative funding scheme in which researchers collaborating across the department will be eligible to apply for additional funding. 

The Radcliffe Department of Medicine was formed in 2012 through an amalgamation of the Departmentof Cardiovascular Medicine, the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), the majority of research groups from the MRC Weatherall Institute of Molecular Medicine (WIMM), the Nuffield Department of Clinical Laboratory Sciences, the Oxford Acute Vascular Imaging Centre (AVIC) and the academic groups in Geratology and Stroke who were formerly members of the Nuffield Department of Medicine,  Experimental Medicine Division. These latter groups, together with a new programme in Experimental Therapeutics and the new Centre for the Advancement of Sustainable Medical Innovation (CASMI), will now constitute the Investigative Medicine Division (IMD) of RDM.

Head of Department, Professor Hugh Watkins commented: “The motivation for forming the RDM was to bring groups together that could add value to one another and I think the breadth and quality of research presented today shows just how great the potential is."

Links: 

Radcliffe Department of Medicine

Medical Sciences Division

Similar stories

EAVI2020: The Quest for an HIV Vaccine

In this long read published to coincide with International AIDS Day, we explore how an international collaboration – of which the University of Oxford is a key partner – has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.

Smoking increases the risks of 56 diseases in Chinese adults

Smoking increases the risks of 56 diseases and kills more than one million adults in China each year from 22 different causes, according to new research published in The Lancet Public Health.

Treating mental illness with electricity marries old ideas with modern tech and understanding of the brain – podcast

Young lives under pressure as global crises hits mental health and well-being – report

The well-being and mental health of young people in low - and middle - income countries have been dramatically affected by the series of crises hitting the world. As the international community continues to struggle with the impact of COVID-19, conflict and climate change, the latest report from the Young Lives project shows a long-running upward trend in young people’s well-being has been sharply reversed alongside widespread anxiety and depression. Young people are less confident about their futures for the first time in the 20-year study.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

First evidence drug resistant bacteria can travel from gut to lung, increasing infection risks

A new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide the first direct evidence of AMR bacteria migrating from a patient’s gut microbiome to the lungs, increasing the risk of deadly infections.